Cargando…

Modification of Ad5 Hexon Hypervariable Regions Circumvents Pre-Existing Ad5 Neutralizing Antibodies and Induces Protective Immune Responses

The development of an effective malaria vaccine is a high global health priority. Vaccine vectors based on adenovirus type 5 are capable of generating robust and protective T cell and antibody responses in animal models and are currently being evaluated in clinical trials for HIV and malaria. They a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruder, Joseph T., Semenova, Elena, Chen, Ping, Limbach, Keith, Patterson, Noelle B., Stefaniak, Maureen E., Konovalova, Svetlana, Thomas, Charlie, Hamilton, Melissa, King, C. Richter, Richie, Thomas L., Doolan, Denise L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320611/ https://www.ncbi.nlm.nih.gov/pubmed/22496772 http://dx.doi.org/10.1371/journal.pone.0033920

Ejemplares similares

Correction: Modification of Ad5 Hexon Hypervariable Regions Circumvents Pre-Existing Ad5 Neutralizing Antibodies and Induces Protective Immune Responses
por: Bruder, Joseph T., et al.
Publicado: (2012)

P17-13. Hexon hypervariable regions 4–7 contain important Ad5-specific neutralizing antibody epitopes
por: Bradley, RR, et al.
Publicado: (2009)

Interaction between hexon and L4-100K determines virus rescue and growth of hexon-chimeric recombinant Ad5 vectors
por: Yan, Jingyi, et al.
Publicado: (2016)

HIV Antigen Incorporation within Adenovirus Hexon Hypervariable 2 for a Novel HIV Vaccine Approach
por: Matthews, Qiana L., et al.
Publicado: (2010)

Optimization of vaccine responses with an E1, E2b, E3 deleted Ad5 vector circumvents pre-existing anti-vector immunity
por: Osada, Takuya, et al.
Publicado: (2009)

Retargeting FX-binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loop
por: Robertson, Stacy, et al.
Publicado: (2016)

A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine
por: Fonseca, Jairo Andres, et al.
Publicado: (2016)

Manipulating Adenovirus Hexon Hypervariable Loops Dictates Immune Neutralisation and Coagulation Factor X-dependent Cell Interaction In Vitro and In Vivo
por: Ma, Jiangtao, et al.
Publicado: (2015)

Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon
por: Haque, Ezazul, et al.
Publicado: (2018)

Twistor methods for AdS$_5$
por: Adamo, Tim, et al.
Publicado: (2016)

Quantum Fishchain in $AdS_5$
por: Gromov, Nikolay, et al.
Publicado: (2019)

Baseline Ad5 serostatus does not predict Ad5-HIV vaccine-induced expansion of Ad-specific CD4+ T-cells
por: Hutnick, Natalie A., et al.
Publicado: (2009)

Correction: Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon
por: Haque, Ezazul, et al.
Publicado: (2018)

Altering the Ad5 Packaging Domain Affects the Maturation of the Ad Particles
por: Alba, Raul, et al.
Publicado: (2011)

Hydropathic characteristics of adenovirus hexons
por: Li, Q.-G., et al.
Publicado: (1997)

Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination
por: Cheng, Cheng, et al.
Publicado: (2012)

Binding of adenovirus species C hexon to prothrombin and the influence of hexon on vector properties in vitro and in vivo
por: Tian, Jie, et al.
Publicado: (2022)

Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures
por: Stepanenko, Aleksei A., et al.
Publicado: (2021)

rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1
por: Montefiori, DC, et al.
Publicado: (2012)

Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination
por: Cheng, Cheng, et al.
Publicado: (2012)

Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses
por: Bradshaw, Angela C., et al.
Publicado: (2012)

Icosahedral gold nanoparticles decorated with hexon protein: a surrogate for adenovirus serotype 5
por: Fresco-Cala, Beatriz, et al.
Publicado: (2022)

$AdS_{5}$ Superalgebras with Brane Charges
por: Ferrara, S., et al.
Publicado: (1999)

Exploring the Impact of Adding a Respiratory Dimension to the EQ-5D-5L
por: Hoogendoorn, Martine, et al.
Publicado: (2019)

Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection
por: Tamminga, Cindy, et al.
Publicado: (2013)

ALPHA (AD-5) Status Report for 2014
por: Hangst, JS
Publicado: (2015)

$AdS_{5}$ and the 4D Cosmological Constant
por: Schmidhuber, Christof
Publicado: (1999)

Tools for deconstructing gauge theories in AdS(5)
por: de Blas, Jorge, et al.
Publicado: (2006)

Microstates of supersymmetric black holes in AdS5
por: Murthy, Sameer
Publicado: (2021)

Microstates of supersymmetric black holes in AdS5
por: Murthy, Sameer
Publicado: (2021)

Microstates of supersymmetric black holes in AdS5
por: Murthy, Sameer
Publicado: (2021)

Microstates of supersymmetric black holes in AdS5
por: Murthy, Sameer
Publicado: (2021)

Vaccination with Ad5 Vectors Expands Ad5-Specific CD8(+) T Cells without Altering Memory Phenotype or Functionality
por: Hutnick, Natalie A., et al.
Publicado: (2010)

EXPERIMENTAL LIVER NECROSIS; I. THE HEXON BASES
por: Jackson, Holmes C., et al.
Publicado: (1907)

Adding unaligned sequences into an existing alignment using MAFFT and LAST
por: Katoh, Kazutaka, et al.
Publicado: (2012)

Adding Pluggable and Personalized Natural Control Capabilities to Existing Applications
por: Lamberti, Fabrizio, et al.
Publicado: (2015)

Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine
por: Schmidt, Katja G., et al.
Publicado: (2023)

Intracardiac injection of a capsid-modified Ad5/35 results in decreased heart toxicity when compared to standard Ad5
por: Toivonen, Raine, et al.
Publicado: (2012)

Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions
por: Yang, Wei-Xiong, et al.
Publicado: (2016)

A Crossing-Symmetric Phase for $AdS_{5} x S^{5}$ Strings
por: Beisert, N, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_gbg0r0ov23o1hjvdqmt638c6be